In this week’s Pathways Picks: A potentially eventful week ahead, as the EPA must issue its ethylene oxide emissions rule, with massive potential impacts on device production, and the US Congress has to reach a funding agreement to prevent a government shutdown by this Friday. Also, the UK’s top regulator announces plans to retire, CDRH’s TAP program has a new leader, FDA is pressured on stalled diversity guidance, and European IVDR and data rule updates.
Welcome to MyStrategist
Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today
Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market PathwaysStart Trial
Launched as a novel collaboration between The Foundry and a major strategic, Ireland-based FIRE1 hopes to revolutionize the way we treat heart failure by, in effect, treating patients as consumers and taking heart failure into an era of deeper patient engagement.
Don't Just Advertise... Strategize!
Advertise with MedTech Strategist and be seen by medtech's most influential executives.Learn More
MHRA has selected the first devices for its eight devices for its IDAP pilot. Excerpted from Pathways' Picks February 21: FDA in London, UK Innovative Devices, Maisel Retirement, and More.